International Journal of Cardiology
Volume 76, Issue 2 , Pages 173-180 , November 2000

Vectorcardiographic changes during cardioangiography with iodixanol and ioxaglate

Received 22 March 2000 ,Revised 1 September 2000 ,Accepted 4 September 2000.

References 

  1. Hirshfeld JWJ. Cardiovascular effects of iodinated contrast agents. Am J Cardiol. 1990;66:9F–17F
  2. Dawson P. Cardiovascular effects of contrast agents. Am J Cardiol. 1989;64:2E–9E
  3. Pedersen HK, Jacobsen EA, Refsum H. Contrast media-induced ventricular fibrillation: an experimental study of the effects of dimeric contrast media during wedged catheter injection in dogs. Acad Radiol. 1994;1:136–144
  4. Andersen PE, Bolstad B, Berg KJ, Justesen P, Thayssen P, Kloster YF. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study. Clin Radiol. 1993;48:268–272
  5. Fransson SG, Stenport G, Andersson M. Immediate and late adverse reactions in coronary angiography. A comparison between iodixanol and ioxaglate. Acta Radiol. 1996;37:218–222
  6. Flinck A, Selin K, Dellborg M, Skinningsrud K, Ekholm S. Addition of sodium to iohexol. A vectorcardiographic study. Acta Radiol. 1994;35(6):619–625
  7. Flinck A, Selin K, Björneld L, Nossen JØ. Iodixanol and iohexol in cardioangiography. A comparative vectorcardiographic study. Acta Radiol. 2000;41:384–389
  8. Frank E. An accurate, clinically practical system for spatial vectorcardiography. Circulation. 1956;XIII:737–749
  9. Jones B, Kenward MG. In: Design and analysis of cross-over trials. London: Chapman&Hall; 1989;
  10. Grendahl H, Eie H, Nordvik A, Müller C. Electrocardiographic changes during selective coronary angiography. Acta Med Scand. 1972;191:493–500
  11. Smith RF, Harthorne WJ, Sanders CA. Vectorcardiographic changes during intracoronary injections. Circulation. 1967;36:63–76
  12. Platou ES, Steinnes K, Refsum H. A method for simultaneous epicardial monophasic action potential recordings from the dog heart in situ. Acta Pharmacol Toxicol (Copenh). 1984;54:94–103
  13. Shabetai R, Surawicz B, Hammill W. Monophasic action potentials in man. Circulation. 1968;38:341–352
  14. Jacobsen EA, Kløw NE, Mortensen E, Refsum H. Sodium addition to nonionic contrast media. Effects on cardiac monophasic action potentials and hemodynamics in a dog model. Invest Radiol. 1991;26:888–893
  15. Jensen SM, Häggmark S, Johansson G, Näslund U. On-line computerized vectorcardiography: influence of body position, heart rate, radiographic contrast fluid and myocardial ischemia. Cardiology. 1997;88(6):576–584
  16. Kløw NE, Tande PM, Hevrøy O, Refsum H. Mechanism of ECG changes and arrhythmogenic properties of low osmolality contrast media during coronary arteriography in dog. Cardiovasc Res. 1990;24:303–308
  17. Kuo CS, Munakata K, Reddy CP, Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation. 1983;67:1356–1367
  18. Levorstad K, Vatne K, Brodahl U, Laake B, Simonsen S, Aakhus T. Safety of the nonionic contrast medium omnipaque in coronary angiography. Cardiovasc Intervent Radiol. 1989;12:98–100
  19. Armstrong SJ, Murphy KP, Wilde P, Hartnell GG. Ventricular fibrillation in coronary angiography: what is the role of contrast medium?. Eur Heart J. 1989;10(10):892–895
  20. Missri J, Jeresaty RM. Ventricular fibrillation during coronary angiography: reduced incidence with nonionic contrast media [see comments]. Cathet Cardiovasc Diagn. 1990;19:4–7

PII: S0167-5273(00)00376-4

International Journal of Cardiology
Volume 76, Issue 2 , Pages 173-180 , November 2000

Article Tools

* Image Usage & Resolution